Malaria Chemoprevention, Though Effective, Presents Risk Of Antibiotic Resistance

New York Times: Malaria Prevention, With Both Reward and Risk
Amy Maxmen, science journalist

“…With a limited lifetime, chemoprevention is not an ideal solution for malaria. But the situation is desperate. Malaria remains the No. 1 killer in several countries, and a vaccine that reliably and permanently prevents the disease may be more than a decade away from the market. … Despite its flaws, chemoprevention could prevent 8.8 million cases of malaria and 80,000 deaths annually — but right now, it lacks the political support to fund and carry it out to the full extent…” (6/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.